Ashkan Emadi

Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia

Geoffrey L. Uy, Ibrahim Aldoss, Matthew C. Foster et al. · Blood · 2020 · 307 citations · Full text

Inhibition of glutaminase selectively suppresses the growth of primary acute myeloid leukemia cells with IDH mutations

Ashkan Emadi, Sung Ah Jun, Takashi Tsukamoto et al. · Experimental Hematology · 2013 · 156 citations

Hematological Malignancy, Oncogenic Agent, Mixed-phenotype Acute Leukemia +6

Prospective serial evaluation of 2-hydroxyglutarate, during treatment of newly diagnosed acute myeloid leukemia, to assess disease activity and therapeutic response

Amir Fathi, Hossein Sadrzadeh, Darrell R. Borger et al. · Blood · 2012 · 122 citations · Full text

Presence of isocitrate dehydrogenase mutations may predict clinical response to hypomethylating agents in patients with acute myeloid leukemia

Ashkan Emadi, Rawan Faramand, Brandon Carter‐Cooper et al. · American Journal of Hematology · 2015 · 74 citations · Full text

Engineering, Mixed-phenotype Acute Leukemia, Genetics +18

Incidence of symptomatic venous thromboembolism following hospitalization for coronavirus disease 2019: Prospective results from a multi-center study

Farid Rashidi, Stefano Barco, Farin Kamangar et al. · Thrombosis Research · 2020 · 72 citations · Full text